https://www.marketscreener.com/quote/stock/ACTAVIS-PLC-14476989/news/Actavis-Receives-FDA-Approval-for-VIBERZI-eluxadoline-for-the-Treatment-of-Irritable-Bowel-Syndr-20445879/?utm_source=telegram&utm_medium=social&utm_campaign=share